BOPI 07 BR/2023 REPERTOIRE NUMERIQUE 21 Fig. 23 Consulter le mémoire ________________________________________ (11) 21045 (51) A01N 25/10 (2018.01); A01N 59/02 (2018.01); A01N 59/20 (2018.01) ; A01P 3/00 (2018.01) (21) 1202200411 - PCT/IB2021/053291 (22) 21/04/2021 (30) IN n° 202011017328 du 22/04/2020 (54) Laminarin based formulation for agricultural applications. (72) LECOLLINET, Gregory (MU) et PIROTTE, Alan Bruno (MU) (73) 1-UPL CORPORATION LIMITED, 5th Floor, Newport Building, Louis Pasteur Street, PORT LOUIS (MU) et 2-UPL EUROPE LTD., The Centre, 1st Floor, Birchwood Park, WARRINGTON, Cheshire, WA3 6YN (GB) (74) S.C.P AKKUM, AKKUM & Associates, n° 1777, Rue 6.261, Auditorium Jean Paul II, Quartier Mbankolo, B.P. 4966, YAOUNDE (CM). (57) The present invention relates to a composition comprising water soluble actives such as laminarin. Particularly, the present invention relates to a stable composition comprising water soluble actives such as laminarin and a polyol. The present invention also relates to a process for the preparation of said composition and method of use thereof. Formula (I) Consulter le mémoire ________________________________________ (11) 21046 (51) A61K 31/7072 (2018.01); A61K 31/7076 (2018.01) ; A61P 31/14 (2018.01) (21) 1202200416 - PCT/EP2021/059504 (22) 13/04/2021 (30) EP n° 20169480.9 du 14/04/2020 (54) BI- and monocyclic nucleoside analogs for treatment of hepatitis E. (72) JONCKERS, Tim, Hugo, Maria (BE); PAUWELS, Frederik (BE) et DEBING, Yannick (BE) (73) JANSSEN PHARMACEUTICALS, INC., 1125 Trenton-Harbourton Road, TITUSVILLE, New Jersey 08560 (US)
RkJQdWJsaXNoZXIy MTM1NDc3MA==